Michael F. MacLean, CFO: Avidity Biosciences RNA Sell · Filed 01/23

Trade details

Type: Insider sale
Amount: $130,917.15
Shares · price: 1,807 sh · $72.45 a share
Held after: 62,025 sh
Stock: Avidity Biosciences RNA
Person: Michael F. MacLeanCFO
Trade date: 26/01/21
Filed: 26/01/23
Days to filing: 2 days

Sold 2.8% of holdings

Share of holding sold: 2.8%

Avidity Biosciences trades, last 26 weeks

What else happened in Avidity Biosciences around then

Filed or reported within 30 days of the trade day · 25/12/22~02/20

Michael F. MacLean's recent trades

Michael F. MacLeanCFO
Sell10b5-1 planAvidity Biosciences
Sell10b5-1 plan
Avidity Biosciences
RNA
$198.2K
2,735 sh
$198.2K
Filed 01/23
Traded 01/21
Michael F. MacLeanCFO
Sell10b5-1 planAvidity Biosciences
Sell10b5-1 plan
Avidity Biosciences
RNA
$142.6K
1,974 sh
$142.6K
Filed 01/09
Traded 01/07
Michael F. MacLeanCFO
Sell10b5-1 planAvidity Biosciences
Sell10b5-1 plan
Avidity Biosciences
RNA
$1.3M
30,914 sh
$1.3M
Filed 25/08/15
Traded 25/08/06
Michael F. MacLeanCFO
Sell10b5-1 planAvidity Biosciences
Sell10b5-1 plan
Avidity Biosciences
RNA
$246.5K
7,935 sh
$246.5K
Filed 25/03/21
Traded 25/03/20
Michael F. MacLeanCFO
Sell10b5-1 planAvidity Biosciences
Sell10b5-1 plan
Avidity Biosciences
RNA
$47.6K
1,665 sh
$47.6K
Filed 25/01/23
Traded 25/01/21

Michael F. MacLean, CFO — sold $130.9K of Avidity Biosciences RNA · 2.8% of holdings · 10b5-1 plan | Whalegun